Pharma14 is happy to announce the addition of Turkey to its global medicine database.
This is just the latest addition to our platform that now comprises close to 2,000,000 registered medicines across 40 countries.
The new data is updated on a monthly basis and covers all the registered Rx and OTC medicines in Turkey.
As in all other countries, Turkey's full medicine data includes pricing, reimbursement information and much more.
Pharma14's robust and accurate medicine data, as well as its industry leading drug pricing and reimbursement information give its members the tools required to compete in today's market.
Key pricing drivers such as generics, parallel trade, biosimillars, niche markets and more provide unique industry insight.
Sample Turkish data: Humira (Adalimumab) Information and ex-factory, wholesale and retail pricing.